Malaria vaccine disappoints in phase II trial

The efficacy of an investigational malaria vaccine waned from 36% to 2.5% over a period of 7 years in Kenya, at which time it was even associated with an excess of cases in areas of high malaria...
Source: Pediatric News - Category: Journals (General) Source Type: news